164 related articles for article (PubMed ID: 14717971)
1. Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits.
Chi L; Gibson G; Peng YW; Bousley R; Brammer D; Rekhter M; Chen J; Leadley R
J Thromb Haemost; 2004 Jan; 2(1):85-92. PubMed ID: 14717971
[TBL] [Abstract][Full Text] [Related]
2. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
Golino P; Ragni M; Cirillo P; D'Andrea D; Scognamiglio A; Ravera A; Buono C; Ezban M; Corcione N; Vigorito F; Condorelli M; Chiariello M
Circ Res; 1998 Jan 9-23; 82(1):39-46. PubMed ID: 9440703
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor - a therapeutic target for thrombotic disorders.
Houston DS
Expert Opin Ther Targets; 2002 Apr; 6(2):159-74. PubMed ID: 12223078
[TBL] [Abstract][Full Text] [Related]
5. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
Del Turco S; De Caterina R
Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
[TBL] [Abstract][Full Text] [Related]
6. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Sørensen BB; Rao LV
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
[TBL] [Abstract][Full Text] [Related]
8. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action.
Rao LV; Ezban M
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S135-43. PubMed ID: 10850580
[TBL] [Abstract][Full Text] [Related]
9. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.
Grover SP; Mackman N
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):709-725. PubMed ID: 29437578
[TBL] [Abstract][Full Text] [Related]
10. The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formation.
Girard TJ; Nicholson NS
Curr Opin Pharmacol; 2001 Apr; 1(2):159-63. PubMed ID: 11714090
[TBL] [Abstract][Full Text] [Related]
11. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.
Gertz SD; Fallon JT; Gallo R; Taubman MB; Banai S; Barry WL; Gimple LW; Nemerson Y; Thiruvikraman S; Naidu SS; Chesebro JH; Fuster V; Sarembock IJ; Badimon JJ
Circulation; 1998 Aug; 98(6):580-7. PubMed ID: 9714116
[TBL] [Abstract][Full Text] [Related]
12. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
Crawley J; Lupu F; Westmuckett AD; Severs NJ; Kakkar VV; Lupu C
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1362-73. PubMed ID: 10807755
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa-dependent arterial thrombus formation.
Barstad RM; Hamers MJ; Stephens RW; Sakariassen KS
Blood; 1995 Jul; 86(1):212-8. PubMed ID: 7795226
[TBL] [Abstract][Full Text] [Related]
14. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
15. Thrombin generation by intimal tissue factor contributes to thrombus formation on macrophage-rich neointima but not normal intima of hyperlipidemic rabbits.
Yamashita A; Matsuda S; Matsumoto T; Moriguchi-Goto S; Takahashi M; Sugita C; Sumi T; Imamura T; Shima M; Kitamura K; Asada Y
Atherosclerosis; 2009 Oct; 206(2):418-26. PubMed ID: 19371874
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
[TBL] [Abstract][Full Text] [Related]
17. Plasma factor Xa inhibition can predict antithrombotic effects of oral direct factor Xa inhibitors in rabbit atherothrombosis models.
Funatsu T; Yamashita A; Kaku S; Iwatsuki Y; Asada Y
Thromb Haemost; 2012 Nov; 108(5):896-902. PubMed ID: 23052641
[TBL] [Abstract][Full Text] [Related]
18. Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood.
Barstad RM; Hamers MJ; Kierulf P; Westvik AB; Sakariassen KS
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):11-6. PubMed ID: 7749805
[TBL] [Abstract][Full Text] [Related]
19. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
Wong PC; Luettgen JM; Rendina AR; Kettner CA; Xin B; Knabb RM; Wexler R; Priestley ES
Thromb Haemost; 2010 Aug; 104(2):261-9. PubMed ID: 20589312
[TBL] [Abstract][Full Text] [Related]
20. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
Abela GS; Picon PD; Friedl SE; Gebara OC; Miyamoto A; Federman M; Tofler GH; Muller JE
Circulation; 1995 Feb; 91(3):776-84. PubMed ID: 7828306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
